The revised US Biosecure Act is returning for discussion in Congress, reviving debates around biotechnology security and the role of foreign firms in America’s health ecosystem.
Show more
The US Senate blocked the bill on Dec. 9, 2024, following which the stock of CDMO companies reacted negatively. Since then, Divi’s Laboratories has gained 1.05%, while Laurus Labs has surged 56.49%. In contrast, Syngene International has declined 23.37%, Neuland Laboratories is down 0.53%, and Jubilant Pharmova has fallen 4.04%.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
'Tariffs Beyond Goods To Services': Raghuram Rajan Sees US HIRE Act As India's Big Worry
AGR Relief For Vodafone Idea Could Unlock Bank Funding, Boost Indus Towers: Citi
US Senate Passes Biosecure Act, Positive For Indian CDMO — Check Details
What Accenture's Q4 Result Means For Indian IT Companies — Read Motilal Oswal's Report
POPULAR
1
Q2 Results Live: Titan Profit Surges, Bharti Airtel Revenue Beats Estimates; Niva Bupa Health Swings To Loss
2
Titan Q2 Results: Profit Surges 59% To Rs 1,120 Crore, Revenue Rises
3
Power Grid Q2 Net Profit Declines; Dividend Of Rs 4.5 Per Share Declared — Check Record Date, Other Details
4
Kimberly-Clark To Buy Kenvue For $40 Billion
5